Serum laminin γ2 monomer as a novel predictive biomarker for hepatocellular carcinoma

被引：0
|
作者：
Koshikawa, Naohiko [1 ]
Yamashita, Taro [2 ]
Nakagawa, Masatoshi [3 ]
Yoshida, Eisaku [3 ]
Yoshimura, Toru [3 ]
Kaneko, Shuichi [4 ]
Seiki, Motoharu [5 ]
机构：
[1] Tokyo Tech, Dept Life Sci Tech, Tokyo, Japan
[2] Kanazawa Univ Hosp, Dept Gen Med, Kanazawa, Ishikawa, Japan
[3] Abbott Japan LLC, Diagnost Div, Tokyo, Japan
[4] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan
[5] Kanazawa Univ, Inst Med Pharma & Hlth Sci, Kanazawa, Ishikawa, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E14-1-3
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma
    Yamashita, Taro
    Koshikawa, Naohiko
    Shimakami, Tetsuro
    Terashima, Takeshi
    Nakagawa, Masatoshi
    Nio, Kouki
    Horii, Rika
    Iida, Noriho
    Kawaguchi, Kazunori
    Arai, Kuniaki
    Sakai, Yoshio
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Honda, Masao
    Kitao, Azusa
    Kobayashi, Satoshi
    Takahara, Shizuko
    Imai, Yasuhito
    Yoshimura, Kenichi
    Murayama, Toshinori
    Nakamoto, Yasunari
    Yoshida, Eisaku
    Yoshimura, Toru
    Seiki, Motoharu
    Kaneko, Shuichi
    HEPATOLOGY, 2021, 74 (02) : 760 - 775
  • [2] SERUM MONOMERIC LAMININ-γ2 AS A NOVEL BIOMARKER FOR HEPATOCELLULAR CARCINOMA
    Kiyokawa, Hirofumi
    Yasuda, Hiroshi
    Okuse, Chiaki
    Matsumoto, Nobuyuki
    Yoshimura, Toru
    Yoshida, Eisaku
    Nakagawa, Masatoshi
    Seiki, Motoharu
    Koshikawa, Naohiko
    Itoh, Fumio
    GASTROENTEROLOGY, 2017, 152 (05) : S298 - S298
  • [3] Serum monomeric laminin-2 as a novel biomarker for hepatocellular carcinoma
    Kiyokawa, Hirofumi
    Yasuda, Hiroshi
    Oikawa, Ritsuko
    Okuse, Chiaki
    Matsumoto, Nobuyuki
    Ikeda, Hiroki
    Watanabe, Tsunamasa
    Yamamoto, Hiroyuki
    Itoh, Fumio
    Otsubo, Takehito
    Yoshimura, Toru
    Yoshida, Eisaku
    Nakagawa, Masatoshi
    Koshikawa, Naohiko
    Seiki, Motoharu
    CANCER SCIENCE, 2017, 108 (07): : 1432 - 1439
  • [4] Serum laminin γ2 monomer as a predictive biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a retrospective cohort study
    Nio, Kouki
    Shimakami, Tetsuro
    Terashima, Takeshi
    Yanagi, Masahiro
    Toyama, Tadashi
    Koshikawa, Naohiko
    Nakagawa, Masatoshi
    Yoshida, Eisaku
    Yoshimura, Toru
    Seiki, Motoharu
    Honda, Masao
    Yamashita, Taro
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] A novel molecular mechanism for the development of hepatocellular carcinoma induced by laminin γ2 monomer
    Funahashi, Nobuaki
    Okada, Hikari
    Yamashita, Taro
    Seiki, Motoharu
    Koshikawa, Naohiko
    CANCER SCIENCE, 2023, 114 : 1130 - 1130
  • [6] Serum Amyloid A is a Novel Prognostic Biomarker in Hepatocellular Carcinoma
    Ni, Xiao-Chun
    Yi, Yong
    Fu, Yi-Peng
    He, Hong-Wei
    Cai, Xiao-Yan
    Wang, Jia-Xing
    Zhou, Jian
    Fan, Jia
    Qiu, Shuang-Jian
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10713 - 10718
  • [7] Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
    Ozaki, Kazuaki
    Toshikuni, Nobuyuki
    George, Joseph
    Minato, Takahiro
    Matsue, Yasuhiro
    Arisawa, Tomiyasu
    Tsutsumi, Mikihiro
    JOURNAL OF CANCER, 2014, 5 (03): : 221 - 230
  • [8] Kallikrein-5 As a Novel Serum Biomarker in Hepatocellular Carcinoma
    Pestana, Roberto Carmagnani
    Hassan, Manal M.
    Ali, Reham Abdelwahab Hassan
    Mohamed, Yehia I.
    Kaseb, Ahmed Omar
    HEPATOLOGY, 2018, 68 : 523A - 523A
  • [9] MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma
    Lin, Yu-Xiang
    Pan, Jun-Yong
    Feng, Wen-Du
    Huang, Tian-Cong
    Li, Cheng-Zong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [10] MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma
    Yu-Xiang Lin
    Jun-Yong Pan
    Wen-Du Feng
    Tian-Cong Huang
    Cheng-Zong Li
    European Journal of Medical Research, 28
12345